Clinical trial · Interventional
Mindfulness Based Smoking Cessation Among Cancer Survivors
Smartphone Application Versus Group Mindfulness-based Smoking Cessation Intervention for Cancer Patients and Survivors: Reach Versus Effectiveness
NCT04038255CI-TRIAL-00094795terminatedPhase 4Results postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Recruitment for the study proved to be a significant challenge, raising important concerns about its overall feasibility.
Summary
Brief summary (as posted)
This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Tobacco Smoking | — | UNRESOLVED | — |
Interventions
Interventions (7)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Brief advice on quitting smoking | Behavioral | — | UNRESOLVED |
| Craving-to-Quit app | Behavioral | — | UNRESOLVED |
| Group MT sessions | Behavioral | — | UNRESOLVED |
| Nicoderm C-Q Transdermal Product | Drug | — | UNRESOLVED |
| Orientation session | Behavioral | — | UNRESOLVED |
| Self-help smoking cessation materials | Behavioral | — | UNRESOLVED |
| Two brief follow-up phone calls | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Usual Care
- description
- Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.
- interventionNames
- Drug: Nicoderm C-Q Transdermal Product
- Behavioral: Brief advice on quitting smoking
- Behavioral: Self-help smoking cessation materials
- type
- EXPERIMENTAL
- label
- Craving-to-Quit app
- description
- Participants in this group will receive one "in-person" or online orientation session, 6-week supply of NRT, the "Craving-to-Quit" app, and two brief follow-up phone calls.
- interventionNames
- Drug: Nicoderm C-Q Transdermal Product
- Behavioral: Orientation session
- Behavioral: Craving-to-Quit app
- Behavioral: Two brief follow-up phone calls
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Be 18 years and older * Cancer survivors (based on the NCI definition - "a person is considered to be a survivor from the time of diagnosis until the end of life" National Cancer Institute Dictionary of Cancer Terms, 2014) * Cancer patients currently in active treatment * Have smoked ≥ 5 cigarettes/day in the past year * Be interested in making a quit attempt in the next 30 days * Own a smartphone (apple/android) * Read/speak English * Able to consent * Have no plans to move in the next 3 months * Are not pregnant or planning to be pregnant in the following 3 months Exclusion Criteria: * Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder) * Are currently being treated for a psychiatric condition * Are currently being treated for smoking cessation, alcoholism, or illicit drug use * Are adults unable to consent * Are individuals who are not yet adults * Are pregnant women * Are prisoners
References
Publications (0)
Data not yet available
No reference posted for this study.